At a glance
ClinicalIndex Comparison RecordN/ACompleted· 409 enrolled
Drug / intervention
Awaken prone positioning ventilationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison the Prescription of Duration of Awaken Prone Positioning Ventilation Duration in COVID-19 Patients: a Randomised Controlled Study
In Brief
A clinical study evaluating Awaken prone positioning ventilation for COVID-19. Completed, enrolled 409 participants across 1 site.
Detailed Summary
Awaken prone positioning (APP) ventilation has been widely accepted as a standard regimen in the management of COVID-19 patients. Physiological studies have proved ventilation/perfusion improvement during APP in COVID-19, which was associated improved oxygenation. However, the optimal duration for APP was not yet demonstrated. In this study, we aimed at the prolonged APP to see whether this could improve patients outcomes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedJan 2023
Enrollment StartJan 2023
Primary CompletionApr 2023
Study CompletionMay 2023
TodayJul 2026
First PostedJan 10, 2023
Enrollment StartJan 11, 2023
Primary CompletionApr 30, 2023
Study CompletionMay 30, 2023
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 3.5 years ago
Interventions
Awaken prone positioning ventilationprocedure
patients were mandated to keep a prone position for at least 12 hours.